Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 - ELITE PHARMACEUTICALS INC /NV/ | v441688_ex23-1.htm |
| 10-K - FORM 10-K - ELITE PHARMACEUTICALS INC /NV/ | v441688_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - ELITE PHARMACEUTICALS INC /NV/ | v441688_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - ELITE PHARMACEUTICALS INC /NV/ | v441688_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ELITE PHARMACEUTICALS INC /NV/ | v441688_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ELITE PHARMACEUTICALS INC /NV/ | v441688_ex31-1.htm |
| EX-21 - EXHIBIT 21 - ELITE PHARMACEUTICALS INC /NV/ | v441688_ex21.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following documents of our report dated June 15, 2015, relating to the consolidated financial statements of Elite Pharmaceuticals, Inc. and Subsidiary included in the Annual Report on Form 10-K of the Company for the year ended March 31, 2016.
Registration Statement No. 333-197694 on Form S-8 dated July 29, 2014
Registration Statement No. 333-163907 on Form S-8 dated December 22, 2009
Registration Statement No. 333-132140 on From S-8 dated March 1, 2006
Registration Statement No. 333-118524 on From S-8 dated August 24, 2004
/s/ Demetrius Berkower LLC
Iselin, New Jersey
June 15, 2016